Skip Navigation
Menu
ACP Journal Club |20 September 2011

Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD

Felix S.F. Ram, PhD, Clinical Pharmacologist

Article, Author, and Disclosure Information
FULL TEXT
Chong J, Poole P, Leung B, Black PN. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(5):CD002309. 21563134

GIM/FP/GP:

Pulmonology:

PDEs are cAMP- or cGMP-specific enzymes that are ubiquitous in humans. Of particular interest is the PDE4 isoenzyme, which hydrolyzes cAMP and is expressed in structural cells of the lung (such as smooth muscle cells and airway epithelium) and inflammatory cells (such as neutrophils, lymphocytes, or macrophages). The systematic review and meta-analysis by Chong and colleagues assessed 12 to 52 weeks of treatment with PDE4 inhibitors (roflumilast and cilomilast) as add-on therapy in COPD....
FULL TEXT
PDF
Not Available
Citations
Citation

Ram FS. Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD. Ann Intern Med. 2011;155:JC3–2. doi: https://doi.org/10.7326/0003-4819-155-6-201109200-02002

Download citation file:

© 2020

×
Permissions

Published: Ann Intern Med. 2011;155(6):JC3-2.

DOI: 10.7326/0003-4819-155-6-201109200-02002

0 Citations

Related Articles
In symptomatic COPD, once-daily triple vs dual therapy reduced moderate or severe exacerbations at 1 year
Annals of Internal Medicine; 169 (4): JC16
In COPD, long-term use of higher doses of inhaled corticosteroids was linked to increased fracture risk
Annals of Internal Medicine; 168 (12): JC71
In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days
Annals of Internal Medicine; 168 (8): JC47
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT
Annals of Internal Medicine; 167 (6): JC31
View MoreView Less

Journal Club
In symptomatic COPD, once-daily triple vs dual therapy reduced moderate or severe exacerbations at 1 year
Annals of Internal Medicine; 169 (4): JC16
In COPD, long-term use of higher doses of inhaled corticosteroids was linked to increased fracture risk
Annals of Internal Medicine; 168 (12): JC71
In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days
Annals of Internal Medicine; 168 (8): JC47
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT
Annals of Internal Medicine; 167 (6): JC31
View MoreView Less

Related Point of Care
Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine; 154 (7): ITC4-1
Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine; 148 (5): ITC3-1
View MoreView Less

Related Topics
Chronic Obstructive Airway Disease
Pulmonary/Critical Care

Chronic Obstructive Airway Disease, Pulmonary/Critical Care.

PubMed Articles
Molecular techniques for respiratory diseases: MicroRNA and extracellular vesicles.
Respirology 2019.
Intraoperative oxygen challenge for toleration of single lung ventilation in a patient with severe obstructive airway disease: A case report.
Ann Med Surg (Lond) 2020;49():28-32.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×